Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM50037076 (CHEMBL3355737) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Evotec UK Ltd Curated by ChEMBL | Assay Description Inhibition of PLC gamma-1 phosphorylation in human Jurkat T cells after 30 mins | Bioorg Med Chem Lett 24: 5818-23 (2014) Article DOI: 10.1016/j.bmcl.2014.10.020 BindingDB Entry DOI: 10.7270/Q2NK3GNT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM50037063 (CHEMBL3355726) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 540 | n/a | n/a | n/a | n/a | n/a | n/a |
Evotec UK Ltd Curated by ChEMBL | Assay Description Inhibition of PLC gamma-1 phosphorylation in human Jurkat T cells after 30 mins | Bioorg Med Chem Lett 24: 5818-23 (2014) Article DOI: 10.1016/j.bmcl.2014.10.020 BindingDB Entry DOI: 10.7270/Q2NK3GNT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM99786 (US9695200, 49) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM108763 (US9695200, 91) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM99737 (US9695200, 46) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM108388 (US9695200, 89) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM107352 (US9695200, 74) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM100765 (US9695200, 61) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98821 (US9695200, 41) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM99790 (US9695200, 50) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM99847 (US9695200, 57) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM88551 (US9695200, 22) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM87738 (US9695200, 11) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM81141 (US9695200, 6) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM99857 (US9695200, 59) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM100784 (US9695200, 62) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM100881 (US9695200, 67) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM103397 (US9695200, 72) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM88535 (US9695200, 20) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM108039 (US9695200, 80) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM107952 (US9695200, 76) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98786 (US9695200, 32) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM88562 (US9695200, 24) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98760 (US9695200, 28) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM88670 (US9695200, 26) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM88653 (US9695200, 25) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T] (Homo sapiens (Human)) | BDBM84007 (CEFIXIME | Cefiximum [Latin] | MLS002222332 | SMR0...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase DrugBank MCE KEGG PC cid PC sid PDB UniChem Similars | PCBioAssay | n/a | n/a | 1.21E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The Scripps Research Institute Molecular Screening Center Curated by PubChem BioAssay | Assay Description Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass... | PubChem Bioassay (2014) BindingDB Entry DOI: 10.7270/Q2NC5ZV0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T] (Homo sapiens (Human)) | BDBM34905 (1,6-dimethyl-3-propyl-pyrimido[5,4-e][1,2,4]triazi...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | PCBioAssay | n/a | n/a | 1.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The Scripps Research Institute Molecular Screening Center Curated by PubChem BioAssay | Assay Description Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass... | PubChem Bioassay (2014) BindingDB Entry DOI: 10.7270/Q2NC5ZV0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T] (Homo sapiens (Human)) | BDBM52817 (2-[(5Z)-5-[(E)-3-(2-furanyl)prop-2-enylidene]-4-ox...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | PCBioAssay | n/a | n/a | 1.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The Scripps Research Institute Molecular Screening Center Curated by PubChem BioAssay | Assay Description Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass... | PubChem Bioassay (2014) BindingDB Entry DOI: 10.7270/Q2NC5ZV0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T] (Homo sapiens (Human)) | BDBM114297 (2-[(3R,6S)-1-acetyl-6-(tosylcarbamoyl)-3,6-dihydro...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | PCBioAssay | n/a | n/a | 2.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The Scripps Research Institute Molecular Screening Center Curated by PubChem BioAssay | Assay Description Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass... | PubChem Bioassay (2014) BindingDB Entry DOI: 10.7270/Q2NC5ZV0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T] (Homo sapiens (Human)) | BDBM18136 (ADP, alpha beta-me | AMPCPP | [({[(2R,3S,4R,5R)-5-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase MCE MMDB PC cid PC sid PDB UniChem Patents Similars | PCBioAssay | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The Scripps Research Institute Molecular Screening Center Curated by PubChem BioAssay | Assay Description Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass... | PubChem Bioassay (2014) BindingDB Entry DOI: 10.7270/Q2NC5ZV0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Bos taurus) | BDBM50259930 (6-(10'Z-heptadecenyl)-salicylicacid | 6-[10'(Z)-he...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.22E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Seoul National University Curated by ChEMBL | Assay Description Inhibition of bovine brain PI-PLCgamma1 | J Nat Prod 61: 867-71 (1998) Article DOI: 10.1021/np970367q BindingDB Entry DOI: 10.7270/Q25Q4VVG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM50037060 (CHEMBL3355311) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Evotec UK Ltd Curated by ChEMBL | Assay Description Inhibition of PLC gamma-1 phosphorylation in human Jurkat T cells after 30 mins | Bioorg Med Chem Lett 24: 5818-23 (2014) Article DOI: 10.1016/j.bmcl.2014.10.020 BindingDB Entry DOI: 10.7270/Q2NK3GNT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T] (Homo sapiens (Human)) | BDBM114292 (2-(2-cyano-3-pyridinyl)-2-methylpropanoic acid met...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | PCBioAssay | n/a | n/a | 2.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
The Scripps Research Institute Molecular Screening Center Curated by PubChem BioAssay | Assay Description Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass... | PubChem Bioassay (2014) BindingDB Entry DOI: 10.7270/Q2NC5ZV0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM99799 (US9695200, 54) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM99779 (US9695200, 48) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM99728 (US9695200, 45) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98918 (US9695200, 44) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98850 (US9695200, 43) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98848 (US9695200, 42) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98813 (US9695200, 39) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98807 (US9695200, 37) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98793 (US9695200, 33) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98779 (US9695200, 30) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM98772 (US9695200, 29) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM88558 (US9695200, 23) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM88537 (US9695200, 21) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM87754 (US9695200, 12) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM81238 (US9695200, 8) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (Homo sapiens (Human)) | BDBM102354 (US9695200, 71) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
Confluence Life Sciences, Inc. US Patent | Assay Description Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added... | US Patent US9695200 (2017) BindingDB Entry DOI: 10.7270/Q20G3H9T | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 274 total ) | Next | Last >> |